These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16720559)

  • 1. Diffuse pulmonary parenchymal involvement in multiple myeloma: antemortem diagnosis.
    Kamble R; Rosenzweig T
    Int J Hematol; 2006 Apr; 83(3):259-61. PubMed ID: 16720559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary and pleural manifestations of multiple myeloma].
    Schelle M; Schreiber C; Knolle J; Florschütz A; Kachel R; Schreiber J
    Pneumologie; 2006 Dec; 60(12):743-8. PubMed ID: 17163315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelomatous effusion with poor response to chemotherapy.
    Kim YM; Lee KK; Oh HS; Park SK; Won JH; Hong DS; Park HS; Park JS; Lee DW
    J Korean Med Sci; 2000 Apr; 15(2):243-6. PubMed ID: 10803706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testicular involvement in IgD multiple myeloma].
    Kawauchi K; Ogasawara T; Yasuyama M; Ohkawa S; Aiba M
    Rinsho Ketsueki; 2001 Nov; 42(11):1128-33. PubMed ID: 11808083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelomatous pleural effusion.
    Ghosh S; Gopal R; Advani SH
    J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inside Haematologica: new concepts in the management of multiple myeloma.
    Haematologica; 2002 Aug; 87(8):786-7. PubMed ID: 12161351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma.
    Rostagno C; Ciolli S
    Ann Hematol; 2006 Sep; 85(9):627-8. PubMed ID: 16705455
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of resistant multiple myeloma with vincristine, adriamycin and dexamethasone (VAD).
    Maniatis A; Stamatellou M; Papanastasiou K
    Chemioterapia; 1987 Jun; 6(2 Suppl):727-8. PubMed ID: 3509532
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung Involvement in Multiple Myeloma - Case Study.
    Niţu M; CriȘan E; Olteanu M; Călăraşu C; Olteanu M; Popescu MR
    Curr Health Sci J; 2014; 40(4):274-6. PubMed ID: 26788357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma with multiple and bulky extramedullary plasmacytomas as initial presentation.
    SAWADA T; NAJIMA Y; OHASHI K; KATO I; MIYAZAWA M; NAKANO M; KOBAYASHI T; YAMASHITA T; AKIYAMA H; SAKAMAKI H
    Rinsho Ketsueki; 2009 Nov; 50(11):1635-40. PubMed ID: 20009440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.
    Sonneveld P; Marie JP; Huisman C; Vekhoff A; Schoester M; Faussat AM; van Kapel J; Groenewegen A; Charnick S; Zittoun R; Löwenberg B
    Leukemia; 1996 Nov; 10(11):1741-50. PubMed ID: 8892677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
    Méndez CE; Hwang BJ; Destian S; Mazumder A; Jagannath S; Vesole DH
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):220-3. PubMed ID: 20511169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.
    Rifkin RM; Gregory SA; Mohrbacher A; Hussein MA
    Cancer; 2006 Feb; 106(4):848-58. PubMed ID: 16404741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligoclonal reconstitution masquerading as myeloma relapse.
    Chim CS; Chan EY
    Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
    [No Abstract]   [Full Text] [Related]  

  • 17. A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.
    Hussein MA; Wood L; Hsi E; Srkalovic G; Karam M; Elson P; Bukowski RM
    Cancer; 2002 Nov; 95(10):2160-8. PubMed ID: 12412170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of multiple myeloma by demonstrating plasma cells in bronchoalveolar lavage].
    Burkhardt O; Dickgreber NJ; Bühling F; Waldburg N; Merker HJ; Welte T
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1951-4. PubMed ID: 14502447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma presenting as Sjogren's syndrome.
    Fadilah SA; Cheong SK
    Am J Hematol; 1999 Jul; 61(3):217-8. PubMed ID: 10398318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.